Can patients with papillary thyroid carcinoma and low postoperative thyroglobulin in the presence of clinically apparent lymph node metastases (cN1) be spared from radioiodine?
Pedro Weslley RosarioGabriela Franco MourãoMaria Regina CalsolariPublished in: Endocrine (2020)
The results suggest that even cN1 patients, given the absence of extensive LNM or other adverse findings, who have low Tg and neck US showing no anomalies after thyroidectomy do not require radioiodine.
Keyphrases
- lymph node
- lymph node metastasis
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- neoadjuvant chemotherapy
- papillary thyroid
- neuropathic pain
- early stage
- radiation therapy
- magnetic resonance
- spinal cord
- sentinel lymph node
- rectal cancer